Literature DB >> 1855577

The Dutch hypothesis (chronic non-specific lung disease) revisited.

H J Sluiter1, G H Koëter, J G de Monchy, D S Postma, K de Vries, N G Orie.   

Abstract

In 1961 the hypothesis (later referred to as the Dutch Hypothesis (DH)) was put forward that asthma, chronic bronchitis and emphysema should be considered as different expressions of one disease entity, in which both endogenous (host) and exogenous (environmental) factors play a role in the pathogenesis. A hereditary predisposition to develop allergy and bronchial hyperreactivity were considered to be important denominators of disease susceptibility. Complications and complicating diseases would also contribute to the ultimate phenotype of the patient. In the present paper we discuss the relevance of this hypothesis in 1990. Until now it has not been refuted; circumstantial evidence in its favour has accumulated, but formal proof is still lacking. Further research should pay more attention to the genetic aspects of the disease. Arguments are presented against the use of the terms asthma, chronic bronchitis, and emphysema as indicators of disease entities, and in favour of the use of an umbrella-term, e.g. chronic non-specific lung disease (CNSLD), provided that, in addition, every patient is characterized using so-called defining criteria.

Entities:  

Mesh:

Year:  1991        PMID: 1855577

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  31 in total

Review 1.  Gender differences in airway behaviour over the human life span.

Authors:  M R Becklake; F Kauffmann
Journal:  Thorax       Date:  1999-12       Impact factor: 9.139

Review 2.  Onset and outcome of asthma in older adults. A clinician's perspective.

Authors:  Charles E Reed
Journal:  Clin Rev Allergy Immunol       Date:  2002-02       Impact factor: 8.667

3.  William Pickles Lecture 1992. What our practices teach us.

Authors:  C Van Weel
Journal:  Br J Gen Pract       Date:  1992-05       Impact factor: 5.386

4.  Genomewide screen for pulmonary function in 200 families ascertained for asthma.

Authors:  Dirkje S Postma; Deborah A Meyers; Hajo Jongepier; Timothy D Howard; Gerard H Koppelman; Eugene R Bleecker
Journal:  Am J Respir Crit Care Med       Date:  2005-05-18       Impact factor: 21.405

5.  Asthma care in general practice--time for revolution?

Authors:  P Littlejohns
Journal:  Br J Gen Pract       Date:  1991-08       Impact factor: 5.386

Review 6.  Treating asthma in the older patient: is there a place for leukotriene modifiers?

Authors:  Mitchell H Grayson; Phillip E Korenblat
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

Review 7.  Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome: Nothing New Under the Sun.

Authors:  Nirupama Putcha; Robert A Wise
Journal:  Immunol Allergy Clin North Am       Date:  2016-08       Impact factor: 3.479

8.  The Nottingham Health Profile: score distribution, internal consistency and validity in asthma and COPD patients.

Authors:  M P Jans; F G Schellevis; J T van Eijk
Journal:  Qual Life Res       Date:  1999-09       Impact factor: 4.147

9.  Pilot analysis of the plasma metabolite profiles associated with emphysematous Chronic Obstructive Pulmonary Disease phenotype.

Authors:  Mikell Paige; Marie D Burdick; Suhyon Kim; Junrui Xu; Jae K Lee; Y Michael Shim
Journal:  Biochem Biophys Res Commun       Date:  2011-09-08       Impact factor: 3.575

Review 10.  Relationship of acute obstructive airway change to chronic (fixed) obstruction.

Authors:  M R Becklake
Journal:  Thorax       Date:  1995-09       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.